Balyasny Asset Management »

ADC Therapeutics SA shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $292k 78k 3.75
2024-03-31 $107k 24k 4.49
2022-06-30 $684k 86k 7.94

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding ADC Therapeutics SA

Redmile Group
TCG Crossover Management
Prosight Management
BlackRock
Nantahala Capital Management
Morgan Stanley
Point72 Asset Management
Eventide Asset Management
Millennium Management
Goldman Sachs Group
State Street Corporation
Bank of America Corporation
OrbiMed Advisors
Geode Capital Management
Vanguard Group

View all funds holding ADC Therapeutics SA